These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19665071)

  • 21. How wild-type TP53 is inactivated in undifferentiated-type gastric carcinomas: analyses of intratumoral heterogeneity in deletion and mutation of TP53.
    Yoshimura A; Sugihara H; Ling ZQ; Peng DF; Mukaisho K; Fujiyama Y; Hattori T
    Pathobiology; 2006; 73(1):40-9. PubMed ID: 16785766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations of the p16/MTS1-tumor suppressor gene in gastric cancer.
    Günther T; Schneider-Stock R; Pross M; Manger T; Malfertheiner P; Lippert H; Roessner A
    Pathol Res Pract; 1998; 194(12):809-13. PubMed ID: 9894245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Altered expression of PTEN gene and LOH of its epigenetic microsatellite in gastric carcinoma].
    Li JY; Zheng HC; Yang L; Xu L; Yang XF; Gao H; Zhang YC; Xin Y
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):389-92. PubMed ID: 15355640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
    Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
    Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration.
    Marsit CJ; Zheng S; Aldape K; Hinds PW; Nelson HH; Wiencke JK; Kelsey KT
    Hum Pathol; 2005 Jul; 36(7):768-76. PubMed ID: 16084946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Research on the mechanisms of PTEN gene inactivation in ovarian cancer].
    Lü QJ; Zhao XD; Song JY; Li XH; Ma Y; Meng H; Jiang WG
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):266-9. PubMed ID: 16181546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation.
    Zhou XP; Gimm O; Hampel H; Niemann T; Walker MJ; Eng C
    Am J Pathol; 2000 Oct; 157(4):1123-8. PubMed ID: 11021816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.
    Xu B; Hamada S; Kusuki I; Itoh R; Kitawaki J
    Gynecol Oncol; 2011 Feb; 120(2):239-46. PubMed ID: 21130491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
    Libè R; Groussin L; Tissier F; Elie C; René-Corail F; Fratticci A; Jullian E; Beck-Peccoz P; Bertagna X; Gicquel C; Bertherat J
    Clin Cancer Res; 2007 Feb; 13(3):844-50. PubMed ID: 17289876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma.
    Abdel-Rahman MH; Yang Y; Zhou XP; Craig EL; Davidorf FH; Eng C
    J Clin Oncol; 2006 Jan; 24(2):288-95. PubMed ID: 16344319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas.
    Gimm O; Chi H; Dahia PL; Perren A; Hinze R; Komminoth P; Dralle H; Reynolds PR; Eng C
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1801-5. PubMed ID: 11297621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis.
    Ali-Fehmi R; Khalifeh I; Bandyopadhyay S; Lawrence WD; Silva E; Liao D; Sarkar FH; Munkarah AR
    Int J Gynecol Pathol; 2006 Jul; 25(3):223-9. PubMed ID: 16810057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
    Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
    Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of allelic loss and PTEN mutations in malignant gliomas from Malay patients.
    Zainuddin N; Jaafar H; Isa MN; Abdullah JM
    Med J Malaysia; 2004 Oct; 59(4):468-79. PubMed ID: 15779579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTEN deletion is rare but often homogeneous in gastric cancer.
    Mina S; Bohn BA; Simon R; Krohn A; Reeh M; Arnold D; Bokemeyer C; Sauter G; Izbicki JR; Marx A; Stahl PR
    J Clin Pathol; 2012 Aug; 65(8):693-8. PubMed ID: 22639407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PTEN promoter methylation and LOH of 10q22-23 locus in PTEN expression of ovarian clear cell adenocarcinomas.
    Ho CM; Lin MC; Huang SH; Huang CJ; Lai HC; Chien TY; Chang SF
    Gynecol Oncol; 2009 Feb; 112(2):307-13. PubMed ID: 19007975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis.
    Velickovic M; Delahunt B; McIver B; Grebe SK
    Mod Pathol; 2002 May; 15(5):479-85. PubMed ID: 12011252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosome band 16q24 is frequently deleted in human gastric cancer.
    Mori Y; Matsunaga M; Abe T; Fukushige S; Miura K; Sunamura M; Shiiba K; Sato M; Nukiwa T; Horii A
    Br J Cancer; 1999 May; 80(3-4):556-62. PubMed ID: 10408866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infrequent genetic alterations of the PTEN gene in Japanese patients with sporadic prostate cancer.
    Orikasa K; Fukushige S; Hoshi S; Orikasa S; Kondo K; Miyoshi Y; Kubota Y; Horii A
    J Hum Genet; 1998; 43(4):228-30. PubMed ID: 9852672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas.
    Wang SI; Parsons R; Ittmann M
    Clin Cancer Res; 1998 Mar; 4(3):811-5. PubMed ID: 9533551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.